Medizinische Universität Graz - Research portal
Peikert Alexander |
Presentations at scientific and public conferences
Peikert, A; Claggett, BL; Udell, JA; Joseph, J; Hegde, SM; Kim, K; Mao, L; Wang, T; Havighurst, TC; Farkouh, ME; Bhatt, DL; Tattersall, MC; Cooper, LS; Solomon, SD; Vardeny, O
Antibody response to high-dose trivalent vs standard-dose quadrivalent influenza vaccine in patients with high-risk cardiovascular disease: the INVESTED trial.
ACC’s 73rd Scientific Session & Expo. Session; April, 2024; Atlanta, GA, USA. 2024.
[Poster]
Peikert, A; Vaduganathan, M; Claggett, B; Kulac, IJ; Litwin, SE; Zile, MR; Pfeffer, MA; Desai, AS; Jhund, PS; Butt, JH; Rouleau, JL; Lefkowitz, M; McMurray, JJV; Solomon, SD; Packer, M
Abdominal obesity and outcomes in heart failure with preserved ejection fraction:the PARAGON-HF trial.
ACC’s 73rd Scientific Session & Expo. Session; April, 2024; Atlanta, GA, USA. 2024.
[Oral Communication]
Wang, X; Ostrominski, J; Litwin, SE; Cikes, M; Merkely, B; Kosztin, A; Mullens, W; Inciardi, RM; Peikert, A; Pabon, M; Hegde, SM; Skali, H; Shah, AM; Claggett, BL; Packer, M; Pfeffer, MA; McMurray, JJV; Solomon, SD
Obesity and adverse cardiac remodeling in HFpEF: the PARAGON-HF trial.
ACC’s 73rd Scientific Session & Expo. Session; April, 2024; Atlanta, GA, USA. 2024.
[Oral Communication]
Peikert, A; Bart, BA; Vaduganathan, M; Claggett, BL; Kulac, IJ; Kosiborod, MN; Desai, AS; Jhund, PS; Lam, CSP; Inzucchi, SE; Martinez, FA; de Boer, RA; Hernandez, AF; Shah, SJ; Petersson, M; Langkilde, AM; McMurray, JJV; Solomon, SD; Vardeny, O
Effect of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction treated with beta-blockers: the DELIVER trial.
ESC Congress 2023; Amsterdam, Niederlande . 2023.
[Oral Communication]
Peikert, A; Chandra, A; Kosiborod, MN; Claggett, BL; Desai, AS; Jhund, PS; Lam, CSP; Inzucchi, SE; Martinez, FA; de Boer, RA; Hernandez, AF; Shah, SJ; Janssens, SP; Belohlávek, J; Borleffs, CJW; Dobreanu, D; Langkilde, AM; Bengtsson, O; Petersson, M; McMurray, JJV; Solomon, SD; Vaduganathan, M
Effect of dapagliflozin on individual components of the Kansas City Cardiomyopathy Questionnaire in patients with heart failure with mildly reduced or preserved ejection fraction: the DELIVER trial.
Heart Failure 2023; Mai, 2023; Prag, Tschechien. 2023.
[Oral Communication]
Peikert, A; Goyal, P; Vaduganathan, M; Claggett, BL; Kulac, IJ; Miao, ZM; Vardeny, O; Kosiborod, MN; Desai, AS; Jhund, PS; Lam, CSP; Inzucchi, SE; Martinez, FA; de Boer, RA; Hernandez, AF; Shah, SJ; Petersson, M; Langkilde, AM; McMurray, JJV; Solomon, SD
Efficacy and safety of dapagliflozin in the background of polypharmacy among patients with HFmrEF and HFpEF in the DELIVER trial.
Heart Failure 2023; Mai, 2023; Prag, Tschechien. 2023.
[Oral Communication]
Peikert, A; Vaduganathan, M; Claggett, BL; Kulac, IJ; Foà, A; Desai, AS; Jhund, PS; Carberry, J; Lam, CSP; Kosiborod, MN; Inzucchi, SE; Martinez, FA; de Boer, RA; Hernandez, AF; Shah, SJ; Køber, L; Ponikowski, P; Sabatine, MS; Petersson, M; Langkilde, AM; McMurray, JJV; Solomon, SD
Efficacy and Safety of Dapagliflozin in Patients With Heart Failure and Previous Myocardial Infarction.
Scientific Sessions of the American-Heart-Association; Nov, 2023; Philadelphia, PA, USA. 2023.
[Poster]
Peikert, A; Claggett, BL; Kim, K; Udell, JA; Joseph, J; Desai, AS; Farkouh, ME; Hegde, SM; Hernandez, AF; Bhatt, DL; Gaziano, JM; Talbot, HK; Yancy, C; Anand, I; Mao, L; Cooper, LS; Solomon, SD; Vardeny, O
Association of Post-Vaccination Adverse Reactions After Influenza Vaccine With Mortality and Cardiopulmonary Outcomes in Patients With High-Risk Cardiovascular Disease: The INVESTED Trial.
Scientific Sessions of the American-Heart-Association; November, 2022; Chicago, IL, USA. 2022.
[Poster]
Peikert, A; Vaduganathan, M; Mc Causland, F; Claggett, BL; Chatur, S; Packer, M; Pfeffer, MA; Zannad, F; Lefkowitz, MP; Pieske, B; Düngen, HD; McMurray, JJV; Solomon, SD
Effects of sacubitril/valsartan versus valsartan on renal function in patients with type 2 diabetes and heart failure with preserved ejection fraction: PARAGON-HF.
ACC’s 71st Scientific Session & Expo. Session ; April, 2022; Washington, DC, USA. 2022.
[Oral Communication]
Peikert, A; König, S; Rofa, K; Schäfer, I; Dimanski, D; Karnbrock, L; Hoppe, N; Wadle, C; Albrecht, P; von Garlen, S; Hilgendorf, I; Wolf, D; von zur Mühlen, C; Bode, C; Zirlik, A; Merz, J; Stachon, P
P2X4 Deficiency Reduces Atherosclerosis and Plaque Inflammation in Mice.
87th Annual Meeting of the German Society of Cardiology; April, 2021; Mannheim, Deutschland. 2021.
[Poster]
Peikert, A; Kaier, K; Steffens, L; Clemens, A; Bode, C; Zirlik, A; Stachon, P
Inflammatory Activity correlates with Severity of Heart Failure - The Association of hsCRP with Left Ventricular Ejection Fraction, proBNP and NYHA-Class.
85th Annual Meeting of the German Society of Cardiology; April, 2019; Mannheim, Deutschland. 2019.
[Oral Communication]
Peikert, A; Steffens, L; Kaier, K; Clemens, A; Bode, C; Zirlik, A; Stachon, P
Inflammatory Activity Correlates With Severity of Heart Failure - The Association of High Sensitive CRP With Left Ventricular Ejection Fraction, ProBNP and NYHA-Class in a Real-World Cohort.
Scientific Sessions of the American-Heart-Association; November, 2019; Philadelphia, PA, USA. 2019.
[Poster]
Peikert, A; Kaier, K; Merz, J; Ahmed, I; Wolf, D; Hilgendorf, I; Willecke, F; Stachon, P; Zirlik, A
Need of Treating Residual Inflammatory Activity in Coronary Heart Disease: the value of high sensitive CRP and LDL in a Real World Cohort.
84th Annual Meeting of the German Society of Cardiology; März, 2018; Mannheim, Deutschland. 2018.
[Oral Communication]
Peikert, A; Kaier, K; Merz, J; Ahmed, I; Wolf, D; Hilgendorf, I; Willecke, F; Stachon, P; Zirlik, A
Need of Treating Residual Inflammatory Activity in Coronary Heart Disease: the value of high sensitive CRP and LDL in a Real World Cohort.
32thAnnual Meeting, German Society of Atherosclerosis Study (DGAF); April, 2018; Rauischholzhausen, Deutschland. 2018.
[Oral Communication]
Peikert, A; Kaier, K; Merz, J; Ahmed, I; Wolf, D; Hilgendorf, I; Willecke, F; Stachon, P; Zirlik, A
Need of Treating Residual Inflammatory Activity in Coronary Heart Disease: the value of high sensitive CRP and LDL in a Real World Cohort.
Annual Congress 2018, European Society of Cardiology (ESC); August, 2018; München, Deutschland. 2018.
[Poster]
Peikert, A; Kaier, K; Merz, J; Ahmed, I; Wolf, D; Hilgendorf, I; Willecke, F; Stachon, P; Zirlik, A
Need of Treating Residual Inflammatory Activity in Coronary Heart Disease: the value of high sensitive CRP and LDL in a Real World Cohort.
62th Annual Meeting of the Society of Thrombosis and Haemostasis (GTH); Februar, 2018; Wien, Österreich. 2018.
[Poster]
Peikert, A; Kaier, K; Merz, J; Ahmed, I; Wolf, D; Hilgendorf, I; Willecke, F; Stachon, P; Zirlik, A
Need of Treating Residual Inflammatory Activity in Coronary Heart Disease: the value of high sensitive CRP and LDL in a Real World Cohort.
Scientific Sessions of the American-Heart-Association; November, 2017; Los Angeles, CA, USA. 2017.
[Poster]
Heidenreich, A; Stachon, P; Peikert, A; Stachon, P; Michel, N.A; Wolf, D; Hoppe, N; Dufner, B; Bode, C; Idzko, M; Zirlik, A
Extracellular ATP Induces Atherosclerosis and Vascular Inflammation via Purinergic Receptor 2 (P2Y2) in Mice.
81th Annual Meeting of the German Society of Cardiology; April, 2015; Mannheim, Deutschland. 2015.
[Poster]
Peikert, A; Stachon, P; Michel, N.A; Hergeth, S; Wolf, D; Dufner, B; Bode, C; Idzko, M; Zirlik, A
P2Y6 Deficiency Limits Vascular Inflammation and Atherosclerosis in Mice.
29thAnnual Meeting, German Society of Atherosclerosis Study (DGAF); März, 2014; Rauischholzhausen, Deutschland. 2014.
[Oral Communication]
Peikert, A; Stachon, P; Michel, N.A; Wolf, D; Hoppe, N; Dufner, B; Bode, C; Idzko, M; Zirlik, A
Extracellular ATP Induces Atherosclerosis and Vascular Inflammation via Purinergic Receptor 2 (P2Y2) in Mice.
80th Annual Meeting of the German Society of Cardiology; April, 2014; Mannheim, Deutschland. 2014.
[Poster]